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Abstract
The adult human cochlea contains various types of peripheral glial cells that envelop or myelinate the three different
domains of the spiral ganglion neurons: the central processes in the cochlear nerve, the cell bodies in the spiral ganglia, and
the peripheral processes in the osseous spiral lamina. Little is known about the distribution, lineage separation and
maturation of these peripheral glial cells in the human fetal cochlea. In the current study, we observed peripheral glial cells
expressing SOX10, SOX9 and S100B as early as 9 weeks of gestation (W9) in all three neuronal domains. We propose that
these cells are the common precursor to both mature Schwann cells and satellite glial cells. Additionally, the peripheral glial
cells located along the peripheral processes expressed NGFR, indicating a phenotype distinct from the peripheral glial cells
located along the central processes. From W12, the spiral ganglion was gradually populated by satellite glial cells in a
spatiotemporal gradient. In the cochlear nerve, radial sorting was accomplished by W22 and myelination started prior to
myelination of the peripheral processes. The developmental dynamics of the peripheral glial cells in the human fetal cochlea
is in support of a neural crest origin. Our study provides the first overview of the distribution and maturation of peripheral
glial cells in the human fetal cochlea from W9 to W22.
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Introduction
Schwann cells, the major type of peripheral glial cells (PGCs),
envelop and/or myelinate the spiral ganglion neurons (SGNs) in
the cochlea and are essential to normal hearing. Demyelinating
diseases of the peripheral nervous system result in differences in
the velocity of action potential propagation between individual
nerve processes [1]. Depending on the degree of demyelination,
this loss of neural synchrony leads to moderate sensorineural
hearing loss or, if there is a complete conduction block, to deafness
[2–4]. One major peripheral neuropathy affecting hearing is
Charcot-Marie-Tooth disease, a genetically and clinically hetero-
geneous group of disorders which includes mutations in genes that
are involved in myelination [5–8]. Other causes of demyelination
of peripheral nerves, and hence potentially leading to sensorineu-
ral hearing loss, include autoimmune diseases such as the Guillain-
Barre´ syndrome, and infectious diseases such as leprosy [9–12].
Loss of myelin may also be involved in the development of age-
related sensorineural hearing loss [13].
Based on animal studies, it is commonly accepted that all PGCs
derive from the neural crest and migrate along peripheral nerves
to their target locations [14,15]. There, Schwann cell precursors
become immature Schwann cells, which subsequently differentiate
into myelinating or non-myelinating Schwann cell phenotypes
(Fig. 1A). Individual processes of peripheral neurons are singled
out by pro-myelinating Schwann cells in a process known as radial
sorting. Once ensheathment is completed, those Schwann cells will
start to produce myelin, becoming myelinating Schwann cells [14].
The myelin sheath consists of multiple layers of tightly packed
myelin surrounding individual nerve processes and functions to
increase axonal conduction velocity [16]. Non-myelinating
Schwann cells will envelop numerous unmyelinated neuronal
processes, forming the so-called Remak bundles in which the
individual nerve processes remain separated by cytoplasmic
extensions of the non-myelinating Schwann cell [17,18]. Although
Schwann cell differentiation has been investigated extensively, less
is known about the development of a third type of PGCs, satellite
glial cells. Satellite glial cells are thought to play a role in the
microenvironment, protecting, supporting and communicating
with the neuronal cell bodies [19,20]. Avian studies suggest that
satellite glial cells and mature Schwann cells derive from a
common precursor cell expressing the marker S100 [21] (Fig. 1A).
The differentiation cascade that leads to the formation of satellite
glial cells in humans remains to be investigated.
In the adult human cochlea, all three PGC types are intimately
associated with SGNs. SGNs are bipolar or pseudo-unipolar
neurons that transmit electrical signals encoding sound from
cochlear hair cells to the brain. They are usually classified as type I
SGNs (90–95% of the total population) and type II (5–10%)
SGNs. Both processes of the bipolar type I SGNs, the central
process in the cochlear nerve (CN) and the peripheral process in
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the osseous spiral lamina (Fig. 1B–C), are enwrapped in myelin
sheaths that are produced by myelinating Schwann cells [22,23].
The second type of PGCs, the non-myelinating Schwann cells
(Fig. 1C), ensheath but do not myelinate the central and peripheral
processes of the type II SGNs [24,25]. Neither type of Schwann
cells ensheath the peripheral processes (that innervate the cochlear
hair cells in the organ of Corti) beyond the habenula perforata
[26]. In the spiral ganglion (SG), the cell bodies of the SGNs are
enveloped by the third type of PGCs, the satellite glial cells
(Fig. 1C). In contrast to most mammalian species, satellite glial
cells in the human SG seldom myelinate the SGN cell bodies
[13,22,27,28].
PGCs have been observed using light microscopy in the human
SG and along the central processes of SGNs from 11 weeks of
gestation (W11, i.e. 9 weeks of fetal development) onwards [29].
Other reports have looked at earlier stages, but failed to
discriminate between SGNs and PGCs in the SG [30]. Using
electron-microscopy, it appeared that myelination of the central
processes of the SGNs in the CN in humans starts at W20 [31]. At
the peripheral processes, a study using Woelcke’s iron-hematoxylin
method [32] suggested that myelination starts in at W22, although
transmission electron microscopy suggested that it commences at
W24 [33]. However, it cannot be excluded that the onset of
myelination of the peripheral processes is at an earlier stage,
especially since younger specimens were not available to these
authors.
In the present study, we investigated the distribution and
maturation of PGCs in the human fetal cochlea from W9 to W22.
Using immunohistochemistry, we observed PGCs in the cochlea as
early as W9 and we defined their developmental phenotype in the
three domains of the SGNs: (1) their central processes, (2) their cell
bodies, and (3) their peripheral processes. Studies on Schwann cell
development are not only important to investigate the onset of
myelination (which is one indicator for the maturation of the
auditory system and, hence, related to the onset of hearing), but
are also needed to better understand the relationship of Schwann
cells to auditory neuropathies, whether it be congenital disorders
or disorders acquired during adult life.
Materials and Methods
Ethics statement
The use of human fetal material for this study was approved by
the Medical Ethical Committee of the Leiden University Medical
Center (protocol 08.087) and informed written consent was
obtained in accordance with the WMA Declaration of Helsinki
guidelines.
Human fetal cochleae
Twenty-four fetal cochleas were isolated from human fetal
material collected after elective abortion (using vacuum aspira-
tion). Gestational age (in weeks and days) was determined using
obstetric ultrasonography (W9, n = 1; W10, n = 2; W11, n = 1;
W12, n = 2; W14, n = 2; W15, n = 2; W16, n = 2; W17, n = 3;
W18, n = 5; W19, n = 2; W20, n = 1; W22, n = 1). The cochleas
were isolated in PBS, fixed in 4% paraformaldehyde in PBS
overnight at 4uC, decalcified and embedded in paraffin as
previously described [34].
Figure 1. Capturing PGCs in the human cochlea. (A) Schematic
model of PGC development in the human fetal cochlea. Neural crest
cells differentiate via a Schwann cell precursor stage into S100+
immature Schwann cells. The immature Schwann cells subsequently
maturate into myelinating and non-myelinating Schwann cells, and
(presumably) satellite glial cells. (B) Schematic illustration of a mid-
modiolar cut of the adult human cochlea, showing the lower basal turn
(B1), upper basal turn (B2), lower middle turn (M1), upper middle turn
(M2) and the apex (A). (C) Schematic illustration of the PGCs in the adult
human cochlea. Satellite glial cells (green) envelop all SGN cell bodies.
Non-myelinating Schwann cells (light blue) ensheath both the central
and peripheral processes of the type II SGNs (yellow) that innervate the
outer hair cells (OHC). Myelinating Schwann cells (dark blue) ensheath
and myelinate both processes of the type I SGNs (red) that innervate
the inner hair cells (IHC). Beyond the habenula perforata, in the organ of
Corti, neither Schwann cell types ensheath the most distal part of the
peripheral processes of type I and type II SGNs.
doi:10.1371/journal.pone.0088066.g001
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Immunofluorescence
The cochleas were cut (5 mm sections) in the sagittal plane using
a RM2255 microtome (Leica). Sections were deparaffinized using
standard procedures and immunohistochemistry was performed as
previously described [34]. Briefly, sections were treated 12 min-
utes at 97uC with 0.01M sodium citrate buffer (pH 6.0) for antigen
retrieval, blocked with 1% bovine serum albumin (Sigma-Aldrich)
in PBS containing 0.05% Tween-20 (Promega), and consecutively
incubated with primary and secondary antibodies diluted in
blocking solution. Nuclei were stained with 49,6-diamidino-2-
phenylindole (DAPI, Vector Laboratories). The primary antibod-
ies used in this study were rabbit anti-myelin basic protein (MBP,
1:4000, A0623, DAKO), mouse anti-myosin VIIa (MYO7A, 1:40,
138-1 supernatant, DSHB), rabbit anti-nerve growth factor
receptor (NGFR, 1:200, 07-476, Millipore), chicken anti-periph-
erin (PRPH, 1:200, ab39374, Abcam), rabbit anti-S100 calcium
binding protein B (S100B, 1:200, ab52642, Abcam), rabbit anti-
SOX9 (1:200, ab5535, Millipore), goat anti-SOX10 (1:50, sc-
17342, Santa Cruz), and mouse anti-class III b-tubulin (TUBB3,
1:200, ab78078, Abcam). The secondary antibodies used were
Alexa Fluor (AF) conjugated immunoglobulins (Life Technologies):
AF 488 donkey anti-mouse (A-21202), AF 488 donkey anti-rabbit
(A-21206), AF 488 donkey anti-goat (A-11055), AF 488 goat anti-
chicken (A-11039), AF 568 donkey anti-mouse (A-10037), AF 568
donkey anti-rabbit (A-10042), AF 647 donkey anti-mouse (A-
31571), AF 647 donkey anti-rabbit (A-31573) and AF 647 donkey
anti-goat (A-21447), all at 1:500 dilution. As antibody specificity
controls, primary antibodies were omitted and rabbit immuno-
globulin fraction (X0903, DAKO) was used to confirm that the
cytoplasmic fluorescence observed in all SGN cell bodies when
using higher concentrations of the MBP-antibody was non-
specific.
Image acquisition and processing
Confocal images were made with either a Leica TCS SP5
inverted or a Leica SP8 upright microscope, operating under the
Leica Application Suite Advanced Fluorescence software (LAS AF)
using Leica objectives (206/0.5 dry HCX PL Fluotar; 406/1.3 oil
HC PL Apo; 636/1.4 oil HC PL Apo; 1006/1.4 oil HCX PL
Fluotar). Maximal projections were obtained from image stacks
that were generated by scanning sections throughout their full
depth with z-steps of 0.5 mm, or with a sampling density according
to the Nyquist rate when image restoration (deconvolution) was
applied using Huygens Professional version 4.3.1 software
(Scientific Volume Imaging). Brightness and contrast adjustments
consistent with image manipulation policies were performed either
with LAS AF, ImageJ version 1.47a (National Institutes of Health,
http://imagej.nih.gov/ij) or Adobe Photoshop CS6 (Adobe
Systems) image-processing software.
Results
Human W9 fetal cochlea contains SOX9+/SOX10+/
S100B+ PGCs
To our knowledge, the presence of PGCs has not been reported
in human fetal cochleas younger than W11 [29]. Here, we have
investigated the distribution and phenotype of PGCs at W9, the
youngest cochlear specimen we were able to obtain. At W9, the
cochlear duct consisted of one full turn, the future basal turn. To
identify PGCs, we immunostained for SOX10 (a nuclear marker
Figure 2. PGCs expressed SOX10, SOX9 and S100B in the W9 human fetal cochlea. (A–E) Confocal images of a cochlea at W9 showing DAPI
(A), TUBB3 (B), SOX10 (C), and S100B (D) and the merged image (E). The spiral ganglion is delineated by the dotted line. (F–H) Confocal images of a
cochlea at W9 showing the cochlear nerve (F), the spiral ganglion in the upper basal turn (G), and the spiral ganglion in the lower basal turn (H),
delineated with dotted lines and immunostained with antibodies against SOX9 and TUBB3. Cell nuclei were visualized with DAPI. Abbreviations: B1,
lower basal turn; B2, upper basal turn; SG, spiral ganglion. Scale bar = 100 mm.
doi:10.1371/journal.pone.0088066.g002
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for PGCs regardless of developmental stage [35,36]), S100B (a
cytoplasmic marker expressed in animals by immature and mature
Schwann cells but not by Schwann cell precursors [37,38]) and
TUBB3 (a general marker of SGNs) (Fig. 2A–H). In the CN,
abundant SOX10+/S100B+ PGCs were detected surrounding
essentially all central processes (Fig. 2E). SOX10+/S100B+ PGCs
were also observed at the peripheral processes in the lower (B1)
and the upper (B2) basal turn of the SG (Fig. 2E). In the SG, we
identified SOX10+/S100B+ PGCs mainly along its edge and only
a few in its center (Fig. 2E). Immunostaining for SOX9, a nuclear
neural crest and PGC marker [39,40], revealed a similar pattern of
expression to SOX10 and S100B in PGCs (Fig. 2F–H), indicating
that at W9 the majority of PGCs located along the neuronal
processes have passed the SOX9+/SOX10+/S100B2 progenitor
phase and have developed into a more mature SOX9+/SOX10+/
S100B+ phenotype. Based on their distribution density, these
PGCs most likely migrate from the central processes to the
peripheral processes along the periphery of the SG and may start
colonizing the SG giving rise to the satellite glial cells.
SOX9+/SOX10+/S100B+ PGCs invade the SG in a
spatiotemporal gradient
The developing human cochlea is characterized by distinct
temporal and a spatial gradients at various levels including hair
cell development, organ of Corti maturation, and hair cell
innervation [34]. Therefore, we investigated whether PGCs in
the SG displayed a similar developmental pattern within the
cochlea.
In the lower basal turn (B1) between W9 and W10.4, we
observed an increased number of PGCs in the center of the SG
(Fig. 2C–J and Fig. 3A–G), in agreement with our hypothesis that
SOX9+/SOX10+/S100B+ PGCs gradually colonize the SG,
there differentiating into satellite glial cells. At a higher magnifi-
cation, the central region of the SG showed the formation of a
network of PGCs between the cell bodies of the SGNs (Fig. 3H–J).
However, PGCs at this stage (W10.4) did not yet cluster with the
cell bodies of the SGNs. S100B+ PGCs were present along the
peripheral processes as far as the most distal tips of those processes,
right underneath the prosensory domain of the cochlear duct
(Fig. 3K–M). In addition to the SGNs, the epithelium of the
cochlear duct also weakly immunostained for TUBB3, with the
brightest fluorescence in the prosensory domain (Fig. 3F and 4B).
By W12, dense immunostaining for S100B was observed in the
lower basal turn (B1) of the SG (Fig. 4A–D, right arrow in D),
suggesting the presence of many PGCs. In addition, a spatial
gradient was visible in a basal-to-apical direction. From B1 to the
upper middle turn (M2), S100B immunostaining was progressively
less prominent in the center of the SG and PGCs were primarily
present at the edge of the SG in M2 (Fig. 4A–D, left arrow in D).
In agreement, immunostaining for SOX9 at W12 confirmed this
basal to apical distribution of PGCs (Fig. 4E–L). We concluded
that, similar to other aspects of cochlear development, PGCs also
show distinct temporal and spatial gradients in colonizing the SG
of the human fetal cochlea.
PGCs envelope SGN cell bodies between W12 and W14
The onset of envelopment of the cell bodies of the TUBB3+
SGNs by the S100B+ PGCs was observed at W12 in the basal turn
of the SG (Fig. 5A–H, arrows) and by W14 the cell bodies of all
SGNs in the SG were fully enveloped by S100B+ PGCs (Fig. 5I–
L). By W18, this had become even more pronounced and S100B+
PGCs had become intimately associated with the SGNs (Fig. 5M–
P).
During the process of envelopment, we also noticed changes in
the PGC nuclei. At W12, DAPI staining showed that SGN nuclei
were generally round whereas the nuclei of the enveloping PGCs
tended to be more angular or crescent shaped (Fig. 6Q–R). At
W14, this difference became more prominent. In addition, PGC
nuclei started to get organized around and facing the cell bodies of
the SGNs and exhibited bright yet diffuse DAPI staining (Fig. 6S–
T). By W18, the differences between the PGC nuclei and SGN
nuclei were even more pronounced, with round SGN nuclei
containing prominent nucleoli (Fig. 6U–V), much like the
morphology in adults. At W18, each SGN cell body was
surrounded by one or more PGCs.
At W9, NGFR is expressed in PGCs along the peripheral
processes
The (low affinity) nerve growth factor receptor (NGFR, also
known as p75NTR) is expressed by Schwann cells at various locations
within the adult human cochlea [41] and is expressed in mice and
rats throughout the neural crest and Schwann cell lineages [14].
Immunostaining for NGFR at W9 and W10.4 revealed two
Figure 3. PGCs expressed SOX10, SOX9 and S100B in the
W10.4 human fetal cochlea. (A–B) Confocal images of the lower
basal turn of a W10.4 cochlea immunostained for SOX10 and SOX10
merged with DAPI. (C–D) Confocal images of an adjacent section
immunostained for SOX9 and SOX9 merged with DAPI. (E–G) Confocal
images of the lower basal turn of a W10.4 cochlea immunostained for
S100B (E) and TUBB3 (F) and the merged image with DAPI (G). (H–J)
High-magnification view of the center of the spiral ganglion. (K–M)
Detail of the peripheral processes at their distal end. Abbreviations: cd,
cochlear duct; SG, spiral ganglion. Scale bar = 50 mm (A–G) or 20 mm (H–
M).
doi:10.1371/journal.pone.0088066.g003
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different PGC phenotypes in the developing human cochlea. In the
lower basal turn (B1), PGCs along the peripheral SGN processes
strongly expressed NGFR both at W9 (Fig. 6A–D) and W10.4
(Fig. 6E–I). NGFR immunostaining could even be detected along
the most distal tips of the peripheral processes just underneath the
cochlear duct (Fig. 6I, inset). In contrast, PGCs located at the central
processes in the CN did not express NGFR (Fig. 6A–D). In addition,
a few NGFR+ cells were detected in the SG at W9 (Fig. 6A–D,
asterisk in D), but not at W10.4 (Fig. 6E–I) or later stages.
S100B+/NGFR+ PGCs cells do not penetrate the cochlear
duct epithelium
Since we consistently observed PGCs at the distal tips of the
outgrowing peripheral processes (Fig. 3K–M and the inset in
Fig. 6I), we investigated whether they would initially follow the
peripheral processes into the cochlear duct epithelium, although
Schwann cells are known to be absent in the mature organ of Corti
[26]. We have previously shown that penetration of peripheral
processes into the cochlear duct epithelium is observed in all turns
at W12 and that they targeted and innervated the developing
(future) inner hair cells [34]. At W12 in the upper middle turn
(M2), multiple S100+ PGCs were located directly outside the
cochlear duct epithelium, and although some TUBB3+ neurites
could be seen penetrating into the prosensory domain, S100B
expression could not be observed beyond this border (Fig. 7A–C).
In the lower basal turn (B1), many peripheral processes were found
targeting the first developing hair cell within the cochlear duct
epithelium (Fig. 7D–F, arrowhead). Here, S100B+ PGCs did not
extend into the cochlear duct epithelium either. Immunostaining
for NGFR confirmed these results (Fig. 7G–H, bold arrows).
Expression of NGFR was also evident directly underneath the
cochlear duct epithelium at W14, both in the basal and middle
turns (Fig. 7I–N, bold arrows). Together, these findings indicate
that PGCs do not follow the peripheral processes into the cochlear
duct epithelium during development.
NGFR is expressed by pillar cells within the developing
human organ of Corti
Interestingly, just after the onset of the first hair cell
differentiation at B1 of W12, we also observed weak NGFR
expression within the cochlear duct epithelium in a group of cells
located around the (future) inner hair cell, marked by MYO7A
expression (Fig. 7G–H, thin arrows). At W14, similar weak NGFR
expression was observed at M2 (Fig. 7I–J). At M1, expression was
increased in the cell lateral to the inner hair cell, with a bright
band at its apical surface, corresponding to the cuticular plate
(Fig. 7K–L, thin arrows). At W14, the outer hair cells had also
differentiated at B1 and strong NGFR expression was observed in
the putative outer pillar cell (Fig. 7M–N, thin arrows). In contrast
to the observed NGFR expression, none of the turns at W12–W14
showed any S100B expression in the developing organ of Corti
(data not shown). In the subsequent weeks (i.e., up to W18), similar
NGFR expression patterns were observed both in the PGCs along
the peripheral processes (Fig. 7O–Q) and within the organ of Corti
(Fig. 7R–S).
Myelination has started in the W22 cochlear nerve
Immunostaining for S100B and TUBB3 demonstrated that
PGCs enveloped and bundled groups of nerve fibers in the CN as
early as W9 (Fig. 8A–C). At W22, immunostaining for S100B and
TUBB3 revealed that within the CN many individual TUBB3+
cochlear nerve fibers were ensheathed by S100B+ PGCs (Fig. 8D–
G and the upper inset in Fig. 8G), suggesting that these cells had
differentiated into a promyelinating stage and that radial sorting
was completed. In addition, Remak bundles, the final develop-
mental stage of non-myelinating Schwann cells, were observed in
the CN (the lower inset in Fig. 8G). To investigate myelination, we
Figure 4. A spatial gradient of S100+/SOX9+ PGCs in the W12 human fetal cochlea. (A–D) Confocal images of a cochlea at W12 showing
DAPI (A) TUBB3 (B) and S100B (C) and the merged image (D). In E, the left arrow points to the spiral ganglion in the upper middle turn, whereas the
right arrow points to the spiral ganglion in the lower basal turn. (E–L) Confocal images of a cochlea at W12 immunostained for SOX9 and SOX9
merged with DAPI showing the spiral ganglion at M2 (E–F), M1 (G–H), B2 (I–J) and B1 (K–L). Abbreviations: B1, lower basal turn; B2, upper basal turn;
M1, lower middle turn; M2, upper middle turn. Scale bar = 500 mm (A–D) or 50 mm (E–L).
doi:10.1371/journal.pone.0088066.g004
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analyzed the expression of MBP, a major component of the myelin
sheath. We were unable to detect any MBP expression along the
peripheral processes, nor within the SG nor within the CN up to
W18 (data not shown). At W22, immunostaining for MBP
revealed a few MBP+ tubular structures surrounding individual
TUBB3+ cochlear nerve fibers, indicating that myelination in the
CN had started at least by W22, but not before W18 (Fig. 8H–K).
No MBP expression was observed within the SG or along the
peripheral processes in any of the cochlear turns at W22 (Fig. 9A–
E). To determine if the MBP+ central processes belonged to type I
or type II SGNs, we immunostained the CN at W22 for MPB,
TUBB3 and PRPH (which selectively labels type II SGNs in the
adult human cochlea). In most cases, MBP+ structures were seen
along TUBB3+/PRPH2 cochlear nerve fibers (Fig. 9F–O and the
upper insets in Fig. 9O). However, MBP+ structures along
TUBB3+/PRPH+ cochlear nerve fibers could also be observed,
albeit only a few (Fig. 9K–O and the lower insets in Fig. 9O).
Discussion
On the origin of PGCs in the human cochlea
The assumption that the cells within the cochlea are of dual
embryonic origin has been based on classic experiments using
spotted salamander larvae [42] and chick-quail chimeras [43].
These experiments indicated that whereas the SGNs are derived
from the otic placode, PGCs have a neural crest origin. Recent
research has further confirmed the neural crest origin for PGCs in
the mouse cochlea [44,45], suggesting that the PGC cell origin is
conserved in vertebrates. The pattern of PGC distribution that we
observed in humans at the early gestational stages (W9-12) is in
agreement with the hypothesis of a neural crest origin, with neural
crest cells or early derivatives migrating along the CN into the
human cochlea and populating the SG. Although the develop-
Figure 5. Development of satellite glial cells in the spiral
ganglion. (A–D) Deconvoluted confocal images of the spiral ganglion
in the lower basal turn at W12 showing DAPI (A, blue), TUBB3 (B, red),
S100B (C, green) and the merged image (D). (E–H) High-magnification
view of the spiral ganglion. Arrows point to SGN cell bodies that are
enwrapped by S100B+ satellite glial cells. (I–L) Deconvoluted confocal
images of the spiral ganglion in the lower basal turn at W14 showing
DAPI (I, blue), TUBB3 (J, red), S100B (K, green) and the merged image (L).
(M–P) Deconvoluted confocal images of the spiral ganglion in the lower
basal turn at W18 showing DAPI (M, blue), TUBB3 (N, red), S100B (O,
green), and the merged image (P). (Q–V) High-magnification view of cell
nuclei (DAPI) and S100B+ satellite glial cells within the spiral ganglion at
W12 (Q–R), W14 (S–T) and W18 (U–V). Abbreviations: s, satellite glial cell;
n, spiral ganglion neuron. Scale bar = 10 mm.
doi:10.1371/journal.pone.0088066.g005
Figure 6. Immature Schwann cells along the peripheral
processes express NGFR. (A–D) Confocal images of the lower basal
turn of a cochlea at W9 showing DAPI (A), TUBB3 (B) and NGFR (C) and
the merged image (D). The spiral ganglion is delineated by the dotted
line. The asterisk marks two NGFR+ cells in the center of the spiral
ganglion. (E–I) Confocal images of the lower basal turn of a cochlea at
W10.4 showing DAPI (E), TUBB3 (F), SOX10 (G) and NGFR (H) and the
merged image (I). The spiral ganglion is delineated by the dotted line.
The inset shows a deconvoluted, high-magnification view of TUBB3 and
NGFR at the distal tips of the peripheral processes. Abbreviations: SG,
spiral ganglion. Scale bar = 50 mm or 5 mm (inset in I).
doi:10.1371/journal.pone.0088066.g006
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mental phenotypes of the human PGC remain to be fully
understood, the expression of S100/S100B consistently marks
the transition of Schwann cell precursors into immature Schwann
cells in the rat [37,38]. As S100B was already abundantly
expressed at W9, we concluded that the PGCs in the human
cochlea at this fetal stage correlate with an immature Schwann cell
phenotype. Other differences between Schwann cell precursors
and immature Schwann cells in the rat are the expression of glial-
fibrillary acidic protein (GFAP), OCT6 and O4 or the presence of
a basal lamina [14]. Therefore, in addition to S100B we have
investigated the expression of GFAP, however, this marker was
found to be expressed by SGNs rather than by the PGCs at W12–
W22 (data not shown).
In avian embryos, previous studies have shown that both
satellite glial cells and Schwann cells are derived from a S100+
common precursor cell [21,46]. Based on the onset of association
with SGNs, we hypothesize that the satellite glial cell phenotype
arises in the human cochlea from W12 onwards, as modelled in
Fig. 10. Before this stage, SOX9+/SOX10+/S100B+ PGCs can
be found in and around the SG, matching an immature Schwann
cell phenotype. Therefore, as in animals (reviewed in
[14,15,21,47]), our observations indicate that satellite glial cells,
myelinating Schwann cells and non-myelinating Schwann cells in
the human cochlea also share a common precursor: the S100B+
immature Schwann cell.
Schwann cells along the peripheral processes, a role for
NGFR?
Interestingly, the PGCs along the peripheral processes and
along the central processes in the CN have a different phenotype,
as the former express NGFR whereas the latter do not. NGFR is a
low-affinity receptor for all neurotrophins and can act alone or in
conjunction with Trk-receptors. Among its functions are pro-
grammed cell death (apoptosis), cell survival, neurite outgrowth,
myelination and Schwann cell migration as well as modulation of
synaptic strength [48–50]. Although expression of NGFR has been
reported in Schwann cells in the adult human cochlea [41], its
exact functions in the cochlea remain unknown.
Mouse models have shown that deficiencies or mutations in
NGFR are linked to progressive hearing loss, but have also
Figure 7. NGFR expression in the cochlear duct epithelium. (A–C) Confocal images of the cochlear duct epithelium in the upper middle turn
of a cochlea at W12 showing TUBB3 (A, red), S100B (B, green) and the merged image with DAPI (C). The arrow points to penetrating TUBB3+
peripheral processes. (D–F) Confocal images of the cochlear duct epithelium in the lower basal turn showing TUBB3 (D, red), S100B (E, green) and the
merged image with DAPI (F). The arrowhead points to the first developing (inner) hair cell. (G–H) Confocal images of the cochlear duct epithelium of
the lower basal turn of a cochlea at W12 showing NGFR (G, green) and the merged image with DAPI (H) and MYO7A (red). The bold arrows point to
the NGFR+ Schwann cells. The thin arrows outline the epithelial cells that weakly express NGFR. (I–J) Upper middle turn of a cochlea at W14 showing
NGFR (I, green) and the merged image (J) with DAPI (blue) and MYO7A (red). The bold arrows point to the NGFR+ Schwann cells. (K–L) Lower middle
turn of a W14 cochlea immunostained for NGFR (K, green) and the merged image with DAPI (blue) and MYO7A (red). The bold arrow points to the
NGFR+ Schwann cells. The thin arrow points to a bright band of NGFR. (M–N) Lower basal turn of a W14 cochlea immunostained for NGFR (M, green)
and the merged image (N) with DAPI (blue) and MYO7A (red). The bold arrows point to the NGFR+ Schwann cells. The thin arrow points to a band
brightly immunostained for NGFR. (O–Q) Confocal images of the spiral ganglion in the lower basal turn of a cochlea at W18 showing TUBB3 (O), NGFR
(P, green) and the merged image with DAPI (Q). (R–S) Confocal images of the organ of Corti of a cochlea at W18 showing NGFR (R, green) and the
merged image with DAPI (S). Abbreviations: cd, cochlear duct; m, mesenchyme; B1, lower basal turn; M1, lower middle turn; M2, upper middle turn;
SG, spiral ganglion; PPs, peripheral processes. * = autofluorescence of erythrocytes. Scale bar = 20 mm (A–N, R–S) or 50 mm (O–Q).
doi:10.1371/journal.pone.0088066.g007
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indicated that NGFR is not required for development of hearing
(as tested by auditory-evoked brainstem responses) in the first
postnatal weeks [49,51]. In a study exploring the development of
neural innervation in the mouse cochlea in ErbB2 (a Schwann cell
receptor involved in survival and myelination) null mutants, the
cochlea was found devoid of Schwann cells. Interestingly, in these
mutant cochleas, the peripheral processes of SGNs did overshoot
the organ of Corti, their target location [52]. The authors
speculated that cochlear Schwann cells could normally provide
containment signals guiding neurite outgrowth. Other studies in
chick and mice also indicate that cochlear Schwann cells form
physical corridors and guide SGNs in a reciprocal relationship
[53,54]. Further evidence for this hypothesis comes from a study
using a mouse model of peripheral nerve injury that showed strong
up-regulation of NGFR by Schwann cells [55]. The resulting
increase in NGFR lowered the amount of neurotrophins available
to the injured neurons, thereby inhibiting the regenerating axons
to penetrate from the dorsal root into the spinal cord.
Our data support the hypothesis of a role for Schwann cells in
nerve containment, as we observed a close relationship between
NGFR+ Schwann cells and peripheral processes, as early as W9.
In addition, Schwann cells did not follow when peripheral
processes started to penetrate and explore the cochlear duct
epithelium at W12. Whether or not NGFR plays a role in the
process of axon guidance within the cochlea remains to be
investigated.
NGFR expression in the developing organ of Corti
In the adult human organ of Corti, expression of NGFR has not
been reported [41]. However, studies in mice and rats have
detected transient expression of NGFR in pillar cells, disappearing
Figure 8. Terminal differentiation of Schwann cells in the
cochlear nerve. (A–C) Deconvoluted confocal images of the cochlear
nerve at W9 showing TUBB3 (A, red), S100B (B, green), and the merged
image with DAPI (C). (D–G) Deconvoluted confocal images of an axial
transection of the cochlear nerve at W22 showing DAPI (D), TUBB3 (E),
S100B (F) and the merged image (G). The upper inset in G shows a high-
magnification of TUBB3+ cochlear nerve fibers each enveloped by
S100B+ Schwann cells, the lower inset shows a Remak bundle. (H–K)
Deconvoluted confocal images of a sagittal transection of the cochlear
nerve at W22 showing DAPI (H), TUBB3 (I), MBP (J) and the merged
image (K). The inset shows a high-magnification view of a myelinated
nerve fiber. Scale bar = 10 mm or 1 mm (insets in G and K).
doi:10.1371/journal.pone.0088066.g008
Figure 9. Myelination of spiral ganglion neurons at W22. (A–E)
Confocal images of a spiral ganglion in the middle turn of a cochlea at
W22 showing DAPI (A), TUBB3 (B), PRPH (C), MBP (D) and the merged
image (E). The spiral ganglion is delineated by the dotted line. (F–J)
Confocal images of an axial transection of the cochlear nerve at W22
showing DAPI (F), TUBB3 (G), PRPH (H), MBP (I) and the merged image
(J). (K–O) Deconvoluted confocal images of an axial transection of the
cochlear nerve at W22 showing DAPI (K), TUBB3 (L), PRPH (M), MBP (N)
and the merged image (O). Insets show TUBB3 (left), PRPH (middle) and
the merge with MBP and DAPI (right) in high-magnifications examples
of PRPH2/TUBB3+/MBP+ cochlear nerve fibers (upper inset) and
PRPH+/TUBB3+/MBP+ cochlear nerve fibers (lower inset). Scale
bar = 20 mm or 1 mm (insets in O).
doi:10.1371/journal.pone.0088066.g009
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in the first postnatal week, prior to the onset of hearing in these
animals [49,56–58]. It is thought that hearing in the human foetus
commences at W20 or later [59]; the NGFR expression we
detected in the outer pillar cells at W18 support the view of the
immaturity of the organ of Corti at this stage. It has been proposed
that NGFR expression plays a role in the differentiation or survival
of hair and supporting cells and the formation of the tunnel of
Corti [56]. Interestingly, we observed the strongest expression of
NGFR in the cuticular plate of the outer pillar cell, that is exposed
to the lumen of the cochlear duct. A plausible explanation for this
observation could be that the regulatory effects of NGFR at this
site are mediated by circulating (pro)neurotrophic factors in the
fluid of the cochlea acting on the cuticular plate. However, we are
unaware of studies investigating the presence of such proteins in
the cochlear fluids during development.
No transient myelination of SGNs by satellite glial cells
In contrast to other mammalian species, the majority of the cell
bodies of the SGNs in the adult human are unmyelinated
[13,22,27,28]. Transient myelination of SGN cell bodies during
human fetal development, from W14 onwards, has been suggested
[29]. In the current study, we did not observe any MBP expression
within the human SG between W15 and W22. As myelination of
SGN cell bodies has also not been observed in human neonates or
infants [22,24], it is unlikely that SGNs undergo a period of
transient myelination during human fetal development.
The onset of myelination within the human cochlea
In an extensive evaluation of the developing human fetal CN, it
was reported that myelination of the central processes in the CN
starts at W20 [31]. Myelination of the peripheral processes has
been observed at W24 [33]. We investigated Schwann cells along
peripheral processes up to W22, but did not detect MBP
expression in any of the basal and middle turns. However, at
W22 we observed MBP in the CN. Together, this shows that the
onset of myelination of the CN, at W20, precedes myelination of
the peripheral processes, which occurs between W22 and W24.
In the adult human cochlea, the number of type I SGNs
correlates well with the number of myelinated nerve fibers within
the CN and it is commonly accepted that the unmyelinated fibers
represent type II SGNs [25]. As PRPH selectively immunostains
the central processes of type II SGNs in the adult human cochlea
[60], we examined whether all MBP+ structures surrounded
PRPH-negative fibers. Indeed, most of the fibers surrounded by
MBP did not express PRPH, but few exceptions were observed.
This could indicate that some myelinated cochlear nerve fibers
may be of type II SGN origin. However, as all SGNs express
PRPH early in development [34], we favor the more plausible
alternative explanation that these structures represent (immature)
type I SGNs in the process of downregulating PRPH.
In conclusion, our data provide a comprehensive overview of
PGC development in the human fetal cochlea, which may add to
our understanding of congenital disorders and auditory neurop-
athies and can be used as a basis to evaluate acquired changes
during adult life.
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Figure 10. Model of satellite glial cell development in the human spiral ganglion. Satellite glial cell development and the envelopment of
the cell bodies of SGNs both occur in a temporal and spatial gradient within the spiral ganglion of the developing human fetal cochlea. W10:
Immature Schwann cells (light green) can be found at the edges of the SG in the upper middle turn (M2). In addition, a few Schwann cells are located
in between the SGNs (orange) in the lower basal turn. W12: The number of Schwann cells in between the SGNs has greatly increased in M2. Satellite
glial cells (dark green) in B1 start to envelop the cell bodies of SGNs (red). The pattern in M2 at W12 resembles that in B1 at W10. W14: All SGN cell
bodies in B1 are enveloped by one or more adjacent satellite glial cells. The pattern in M2 resembles that in B1 at W12.
doi:10.1371/journal.pone.0088066.g010
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